| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |